Impact of Site of Care on Infection Rates Among Patients With Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy

Journal of Clinical Immunology - United States
doi 10.1007/s10875-017-0371-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment Costs Associated With Hospital-Based Intravenous Immunoglobulin Therapy Compared to Home-Based Subcutaneous Immunoglobulin Therapy in a Cohort of Paediatric Patients With Primary Immunodeficiency

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2011English

Antibody Levels to Tetanus, Diphtheria, Measles and Varicella in Patients With Primary Immunodeficiency Undergoing Intravenous Immunoglobulin Therapy: A Prospective Study

BMC Immunology
Immunology
2014English

Impact of IVIG vs. SCIG on IgG Trough Level and Infection Rates in Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis of 1,426 Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Socioeconomic Impact of Immunoglobulin Replacement Therapy for Primary Immunodeficiency Patients on the Health Public System in Brazil: A Single Center Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Effect of Intravenous Hydration in Patients Receiving Bisphosphonate Therapy

International Journal of Clinical Pharmacy
ToxicologyPharmacyPharmacologyPharmaceutical Science
2014English

EXPRESS: Central Line Replacement Following Infection Does Not Improve Reinfection Rates in Pediatric Pulmonary Hypertension Patients Receiving Intravenous Prostanoid Therapy

Pulmonary Circulation
PulmonaryRespiratory Medicine
2018English

Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus Vulgaris

Archives of Dermatology
2002English

Primary Immunodeficiency Diseases.

Annals of Internal Medicine
Internal MedicineMedicine
1984English

Primary Immunodeficiency Diseases

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy